PeterASklarMD

PubMed

• 5 citations
  Impact of HIV-1 Resistance-Associated Mutations on Susceptibility to Doravirine: Analysis of Real-World Clinical Isolates.
  Ernest Asante-Appiah, Johnny Lai, Hong Wan, Dongmei Yang, Elizabeth Martin, Peter Sklar, Daria J. Hazuda, Christos J. Petropoulos, Charles M Walworth, Jay A. Grobler> ;Antimicrobial Agents and Chemotherapy. 2021 Sep 27
• 17 citations
  Islatravir in combination with doravirine for treatment-naive adults with HIV-1 infection receiving initial treatment with islatravir, doravirine, and lamivudine: a ph...
  Jean-Michel Molina, Yazdan Yazdanpanah, Alejandro Afani Saud, Christopher J. Bettacchi, Carolina Chahin Anania, Edwin DeJesus, Stephanie O. Klopfer, Anjana Grandhi, Ka...> ;The Lancet. HIV. 2021 Jun 1
• 10 citations
  Brief Report: Switching to DOR/3TC/TDF Maintains HIV-1 Virologic Suppression Through Week 144 in the DRIVE-SHIFT Trial.
  Princy Kumar, Margaret Johnson, Jean-Michel Molina, Giuliano Rizzardini, Pedro Cahn, Markus Bickel, Hong Wan, Zhi Jin Xu, Cristiana Morais, Peter Sklar, Wayne Greaves> ;Journal of Acquired Immune Deficiency Syndromes. 2021 Jun 1
• 18 citations
  Changes in weight and BMI with first-line doravirine-based therapy.
  Chloe Orkin, Richard Elion, Melanie Thompson, Juergen K. Rockstroh, Fernando Alvarez Bognar, Zhi J Xu, Carey Hwang, Peter Sklar, Elizabeth Martin> ;AIDS. 2021 Jan 1
• 13 citations
  Review of Doravirine Resistance Patterns Identified in Participants During Clinical Development.
  Elizabeth Martin, Ming-Tain Lai, Winnie Ngo, Meizhen Feng, Donald J. Graham, Daria J. Hazuda, Sushma Kumar, Carey Hwang, Peter Sklar, Ernest Asante-Appiah> ;Journal of Acquired Immune Deficiency Syndromes. 2020 Dec 15
• 44 citations
  Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority...
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,...> ;The Lancet. HIV. 2020 Jan 1
• 16 citations
  Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Tra...
  Alexander Wong, Deborah Goldstein, Josep Mallolas, Edwin DeJesus, Margaret A. Johnson, Jean-Michel Molina, Anton Pozniak, Anthony Rodgers, Valerie L Teal, Deborah A. H...> ;Journal of Acquired Immune Deficiency Syndromes. 2019 Dec 1
• 47 citations
  Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial.
  Margaret Johnson, Princy Kumar, Jean-Michel Molina, Giuliano Rizzardini, Pedro Cahn, Markus Bickel, Josep Mallolas, Yan Zhou, Cristiana Morais, Sushma Kumar, Peter Skl...> ;Journal of Acquired Immune Deficiency Syndromes. 2019 Aug 1
• 105 citations
  Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immun...
  Chloe Orkin, Kathleen Squires, Jean-Michel Molina, Paul E. Sax, Wing-Wai Wong, Otto Sussmann, Richard Kaplan, Lisa Lupinacci, Anthony Rodgers, Xia Xu, Gina Lin, Sushma...> ;Clinical Infectious Diseases. 2019 Feb 1
• 26 citations
  Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a...
  Pedro Cahn, Richard Kaplan, Paul E. Sax, Kathleen Squires, Jean-Michel Molina, Anchalee Avihingsanon, Winai Ratanasuwan, Evelyn Rojas, Mohammed Rassool, Mark Bloch, Li...> ;The Lancet. HIV. 2017 Nov 1
• 41 citations
  Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease
  Fabrizio Stocchi, Olivier Rascol, Robert A. Hauser, Susan Huyck, A. Tzontcheva, Rachel Capece, Tony W. Ho, Peter Sklar, Christopher Lines, David Michelson, David J. He...> ;Neurology. 2017 Jun 6
• 9 citations
  Influence of Sex/Gender and Race on Responses to Raltegravir Combined With Tenofovir-Emtricitabine in Treatment-Naive Human Immunodeficiency Virus-1 Infected Patients:...
  Kathleen Squires, Linda-Gail Bekker, Christine Katlama, Yazdan Yazdanpanah, Yan Zhou, Anthony Rodgers, Mark J. DiNubile, Peter Sklar, Randi Y. Leavitt, Hedy Teppler> ;Open Forum Infectious Diseases. 2017 Jan 1
• A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder.
  Sellgren CM, Kegel ME, Bergen SE, Ekman CJ, Olsson S, Larsson M, Vawter MP, Backlund L, Sullivan PF, Sklar P, Smoller JW, Magnusson PKE, Hultman CM, Walther-Jallow L, ...> ;Mol. Psychiatry. 2016-10-01
• Genome-wide association study identifies SESTD1 as a novel risk gene for lithium-responsive bipolar disorder.
  Song J, Bergen SE, Di Florio A, Karlsson R, Charney A, Ruderfer DM, Stahl EA, Chambert KD, Moran JL, Gordon-Smith K, Forty L, Green EK, Jones I, Jones L, Scolnick EM, ...> ;Mol. Psychiatry. 2016-09-01
• Copy number variation in bipolar disorder.
  Green EK, Rees E, Walters JTR, Smith K, Forty L, Grozeva D, Moran JL, Sklar P, Ripke S, Chambert KD, Genovese G, McCarroll SA, Jones I, Jones L, Owen MJ, O'Donovan MC,...> ;Mol. Psychiatry. 2016-01-01
• 69 citations
  Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease: Two Randomized Clinical Trials and Lessons Learned
  Robert A. Hauser, Fabrizio Stocchi, Olivier Rascol, Susan Huyck, Rachel Capece, Tony W. Ho, Peter Sklar, Christopher Lines, David Michelson, David J. Hewitt> ;JAMA Neurology. 2015 Dec 1
• Characterization of bipolar disorder patient-specific induced pluripotent stem cells from a family reveals neurodevelopmental and mRNA expression abnormalities.
  Madison JM, Zhou F, Nigam A, Hussain A, Barker DD, Nehme R, van der Ven K, Hsu J, Wolf P, Fleishman M, O'Dushlaine C, Rose S, Chambert K, Lau FH, Ahfeldt T, Rueckert E...> ;Mol. Psychiatry. 2015-06-01
• Evaluating historical candidate genes for schizophrenia.
  Farrell MS, Werge T, Sklar P, Owen MJ, Ophoff RA, O'Donovan MC, Corvin A, Cichon S, Sullivan PF> ;Mol. Psychiatry. 2015-05-01
• Ankyrin-G regulates neurogenesis and Wnt signaling by altering the subcellular localization of β-catenin.
  Durak O, de Anda FC, Singh KK, Leussis MP, Petryshen TL, Sklar P, Tsai L> ;Mol. Psychiatry. 2015-03-01
• Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci.
  Andreassen OA, Harbo HF, Wang Y, Thompson WK, Schork AJ, Mattingsdal M, Zuber V, Bettella F, Ripke S, Kelsoe JR, Kendler KS, O'Donovan MC, Sklar P, McEvoy LK, Desikan ...> ;Mol. Psychiatry. 2015-02-01
• Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia.
  Ruderfer DM, Fanous AH, Ripke S, McQuillin A, Amdur RL, Gejman PV, O'Donovan MC, Andreassen OA, Djurovic S, Hultman CM, Kelsoe JR, Jamain S, Landén M, Leboyer M, Nimga...> ;Mol. Psychiatry. 2014-09-01
• Copy number variation in schizophrenia in Sweden.
  Szatkiewicz JP, O'Dushlaine C, Chen G, Chambert K, Moran JL, Neale BM, Fromer M, Ruderfer D, Akterin S, Bergen SE, Kähler A, Magnusson PKE, Kim Y, Crowley JJ, Rees E, ...> ;Mol. Psychiatry. 2014-07-01
• Evidence that duplications of 22q11.2 protect against schizophrenia.
  Rees E, Kirov G, Sanders A, Walters JTR, Chambert KD, Shi J, Szatkiewicz J, O'Dushlaine C, Richards AL, Green EK, Jones I, Davies G, Legge SE, Moran JL, Pato C, Pato M...> ;Mol. Psychiatry. 2014-01-01
• Replication of bipolar disorder susceptibility alleles and identification of two novel genome-wide significant associations in a new bipolar disorder case-control sample.
  Green EK, Hamshere M, Forty L, Gordon-Smith K, Fraser C, Russell E, Grozeva D, Kirov G, Holmans P, Moran JL, Purcell S, Sklar P, Owen MJ, O'Donovan MC, Jones L, Jones ...> ;Mol. Psychiatry. 2013-12-01
• Detecting large copy number variants using exome genotyping arrays in a large Swedish schizophrenia sample.
  Szatkiewicz JP, Neale BM, O'Dushlaine C, Fromer M, Goldstein JI, Moran JL, Chambert K, Kähler A, Magnusson PKE, Hultman CM, Sklar P, Purcell S, McCarroll SA, Sullivan PF> ;Mol. Psychiatry. 2013-11-01
• Join now to see all

Journal Articles

• Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Is Non-Inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naive Adults with Human Immun...  
  George J Hanna, Peter Sklar, Kathleen E Squires, Paul E Sax, Carey Hwang, Clinical Infectious Diseases